Sales to customers decreased 12.3% year-on-year to 7,026 million yen.

Strong performances from the "Deep Heat" series of anti-inflammatory analgesic products as well as steady results of Dax Cosmetics, a subsidiary acquired in June 2014, contributed to a rise in sales on a local currency basis.

Segment profit (operating income) increased 2.2% year-on-year to 338 million yen.